205 related articles for article (PubMed ID: 27159753)
1. CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
Motohara T; Fujimoto K; Tayama S; Narantuya D; Sakaguchi I; Tashiro H; Katabuchi H
Obstet Gynecol; 2016 Jun; 127(6):1003-1011. PubMed ID: 27159753
[TBL] [Abstract][Full Text] [Related]
2. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
[TBL] [Abstract][Full Text] [Related]
4. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.
Liu M; Mor G; Cheng H; Xiang X; Hui P; Rutherford T; Yin G; Rimm DL; Holmberg J; Alvero A; Silasi DA
Reprod Sci; 2013 May; 20(5):605-15. PubMed ID: 23171677
[TBL] [Abstract][Full Text] [Related]
5. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
[TBL] [Abstract][Full Text] [Related]
6. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
7. The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Pérez-Milán F; Ortiz-Quintana L
Surg Oncol; 2014 Mar; 23(1):40-4. PubMed ID: 24183480
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
Gao Y; Foster R; Yang X; Feng Y; Shen JK; Mankin HJ; Hornicek FJ; Amiji MM; Duan Z
Oncotarget; 2015 Apr; 6(11):9313-26. PubMed ID: 25823654
[TBL] [Abstract][Full Text] [Related]
9. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
[TBL] [Abstract][Full Text] [Related]
10. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Bonneau C; Rouzier R; Geyl C; Cortez A; Castela M; Lis R; Daraï E; Touboul C
Gynecol Oncol; 2015 Jan; 136(1):112-20. PubMed ID: 25449309
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of CD44 expression in ovarian epithelial tumors].
Qu P; Jiao S; Gao Q
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):46-9. PubMed ID: 11783069
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CD44 variant 6 in laryngeal epidermoid carcinomas.
Güler G; Saraç S; Uner A; Karabulut E; Ayhan A; Hiroshi O
Arch Otolaryngol Head Neck Surg; 2002 Apr; 128(4):393-7. PubMed ID: 11926913
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms.
Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL
Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543
[TBL] [Abstract][Full Text] [Related]
16. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
17. Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma.
Jiang H; Qi L; Wang F; Sun Z; Huang Z; Xi Q
Int J Mol Med; 2015 May; 35(5):1374-80. PubMed ID: 25812535
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study.
Ma W; Deng Y; Zhou L
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
[TBL] [Abstract][Full Text] [Related]
20. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
